SBIR/STTR Research Award

Modification of Daptomycin by Combinatorial Biosynthesis

Award identifier ec13ff45f4b67f4101414bfffc2eb0bfac07abec1f4f38fc0a392bdc0e740f28Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$900,000

Program and phase

SBIR · Phase II

Award year

2004

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Open in CaptureIQRequest Access

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
CUBIST PHARMACEUTICALS, INC.
Proposal award date
Not reported
Contract end date
Not reported
UEI
Not reported
Solicitation number
PHS2004-2
Topic code
Not reported

Research abstract

DESCRIPTION (provided by applicant): The antibiotic daptomycin is produced by the Gram-positive bacterium Streptomyces roseosporus and is the first in a new class of investigational drugs called lipopeptides that is being developed by Cubist for the

Technology keywords

Not reported

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

SmartSoloChatGPTClaudePerplexityGrokGemini

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.